Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Parasitol Res ; 120(9): 3307-3317, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34370070

ABSTRACT

The aim of this study was to synthesize several small molecules of the type 5-nitroimidazole-sulfanyl and evaluate biological properties against the main Leishmania species that cause cutaneous leishmaniasis in Venezuela. Final compounds 4-7 were generated through simple nucleophilic substitution of 1-(2-chloroethyl)-2-methyl-5-nitroimidazole 3 with 2-mercaptoethanol, 1-methyl-2-mercaptoethanol, and 2-thyolacetic acid derivative. Compound 8 was synthesized via a coupling reaction between 7 and (S)-Methyl 2-amino-4-methylpentanoate hydrochloride. The inhibitory concentrations of (3, 4, 7, 8) against Leishmania (L.) mexicana and (V.) braziliensis in promastigotes and experimentally infected macrophages were determined by in vitro activity assays. Compounds 7 and 8 shown high activity against both species of Leishmania and were selected for the in vivo evaluation. Animals were infected with promastigotes of the two species and divided into four groups of ten (10) animals and a control group. Intralesional injection way was used for the treatment. The parasitological diagnostic after treatment was obtained by PCR using species specific oligonucleotides. The two Leishmania species were susceptible to compounds 7 and 8 in vivo assays. The results indicated that both compounds reduce significantly (96%) the size of the lesion and cure 63% of the mice infected with L (L) mexicana or L (V) braziliensis as was determined by PCR. The results are indicating that both compounds may represent an alternative treatment for these two Leishmania species.


Subject(s)
Antiprotozoal Agents , Leishmania braziliensis , Leishmania mexicana , Leishmaniasis, Cutaneous , Nitroimidazoles , Animals , Antiprotozoal Agents/pharmacology , Leishmania braziliensis/drug effects , Leishmania mexicana/drug effects , Leishmaniasis, Cutaneous/drug therapy , Mice , Nitroimidazoles/pharmacology
2.
Cell Microbiol ; 4(2): 117-26, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11896767

ABSTRACT

A gene for a Ca2+-transporting ATPase (lmaa1) from the trypanosomatid parasite Leishmania (mexicana) amazonensis was overexpressed in two clones of L. amazonensis differing in their virulence. RNA and protein expression of the gene was increased in transfectants, as was the infectivity of transfectants versus parental types in both mouse and in vitro macrophage infection experiments. The virulence of the almost avirulent clone was enhanced such that it was more virulent than the parental 'virulent' clone. Growth of the parasites in culture as promastigotes, after isolation from mouse lesions, indicated that transfection led to improved survival of promastigotes during the stationary phase of culture. As it is in this culture phase that infective metacyclic forms develop, the key role of the Lmaa1 protein may be in metacyclogenesis. The protein may be important in the synthesis and trafficking of new proteins through the secretory pathway, as we demonstrate, using a green fluorescent protein hybrid and by immunofluorescence, that the Lmaa1 protein is located in the endoplasmic reticulum in promastigotes and amastigotes of L. amazonensis.


Subject(s)
Calcium-Transporting ATPases/metabolism , Leishmania mexicana/metabolism , Leishmania mexicana/pathogenicity , Leishmaniasis, Cutaneous/parasitology , Animals , Calcium-Transporting ATPases/genetics , Cell Line , Endoplasmic Reticulum/parasitology , Female , Gene Expression , Leishmania mexicana/genetics , Leishmania mexicana/growth & development , Macrophages/parasitology , Mice , Mice, Inbred BALB C , Transfection , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...